Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Woodstock Sterile Solutions has appointed pharmaceutical industry veteran Wilfredo Ortiz as General Manager.
read more
GXP-Storage is expanding its UK operations with a third restricted-access facility in Raunds, Northamptonshire, adding more than 95,000 cubic feet of GxP-compliant, environmentally controlled storage capacity.
read more
Wednesday, August 12, 2026
Cycle Pharmaceuticals has selected Forma Life Sciences to establish U.S. commercial manufacturing supply for Cavhanza, an FDA-approved orally disintegrating nilotinib tablet for adults with Philadelphia chromosome-positive chronic myeloid leukemia.
read more
Wednesday, August 12, 2026
Aurisco Pharmaceutical said its Yangzhou, China manufacturing site has passed an FDA pre-approval inspection for inclisiran sodium, describing the facility as the first generic oligonucleotide active pharmaceutical ingredient manufacturer in the ...
read more
Thursday, August 13, 2026
Axtria Inc. announced plans to expand its Forward Deployed Engineering (FDE) organization to 1,000 engineers by December 2026, creating the industry's largest pharma-specific AI engineering team.
read more
Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient development and manufacturing capabilities in Mississauga, Ontario, adding laboratory capacity designed to support complex small-molecule programs.
read more
Clinilabs has appointed biopharma executive Laura Shannon as chief executive officer and promoted founder Gary Zammit, Ph.D., to executive chairperson as the specialty contract research organization expands its global capabilities in central nervous ...
read more
Genprex has selected a U.S.-based contract development and manufacturing organization to scale production of its investigational diabetes gene therapy, moving the program from research-grade manufacturing toward clinical and commercial-ready output.
read more
Lonza has launched a rapid custom media prototyping service designed to help life sciences customers accelerate early-stage development of cell culture media formulations.
read more
Ryvu Therapeutics has launched Keelira, a dedicated early clinical development services business designed to help biotechnology and pharmaceutical companies bring oncology programs into Europe.
read more
Wednesday, August 19, 2026
Piramal Pharma Ltd. has completed the acquisition of an additional 40.67% stake in Hyderabad-based biologics contract development and manufacturing organization Yapan Bio Private Ltd., raising its ownership to 74% and making the company a Piramal ...
read more
Wednesday, August 19, 2026
Cytovance Biologics has launched standalone analytical services for biopharmaceutical companies, allowing clients to access analytical testing without also using the company for development or manufacturing.
read more
Thursday, August 20, 2026
VectorBuilder and Lir Therapeutics have formed a strategic collaboration to develop adeno-associated virus capsids designed to combine biological performance with the manufacturability and scalability needed for clinical gene-therapy programs.
read more
Thursday, August 20, 2026
Charles River Laboratories International and Medigen Vaccine Biologics Corp. have formed a collaboration to support development of Medigen’s next-generation multivalent enterovirus vaccine through next-generation sequencing and other analytical and ...
read more
Halo Pharma is in the final operational stages of activating a new sterile injectable manufacturing line at its Whippany, New Jersey, facility, following a $45 million investment intended to add domestic capacity for pharmaceutical companies.
read more